CEFTIZOXIME SODIUM
PubChem Notes:
Ceftizoxime A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders.
Molecular Formula:
C13H12N5NaO5S2
InChI: InChI=1/C13H13N5O5S2.Na/c1-23-17-7(5-4-25-13(14)15-5)9(19)16-8-10(20)18-6(12(21)22)2-3-24-11(8)18;/h2,4,8,11H,3H2,1H3,(H2,14,15)(H,16,19)(H,21,22);/q;+1/p-1/b17-7-;/t8-,11-;/m1./s1/fC13H12N5O5S2.Na/h16H,14H2;/q-1;m
InChIKey: InChIKey=ADLFUPFRVXCDMO-RKQLQJPLDA
SMILES: CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=CCS3)C(=O)[O-].[Na+]
Names:
CEFTIZOXIME SODIUM
C08118
sodium (6R,7S)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
68401-82-1
Registries:
PubChem CID 9690094
PubChem ID 10318
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|